BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)
The Zepbound (tirzepatide) label recommends switching to a non-oral birth control method, or adding a barrier method, for 4 weeks after starting Zepbound and for 4 weeks after each dose increase
Results May Vary: Individual results will vary based on factors including age, baseline condition, lifestyle factors, dietary habits, physical activity levels, consistency of use, genetic factors, current medications, and other individual variables
Mann JF, Lonn EM, Yi Q, Gerstein HC, Hoogwerf BJ, Pogue J, et al
Nishino T, Okamoto K, Kawaguchi Y, Hori H, Matsumura T, Eger BT, et al
To help your body adjust, we recommend eating smaller, well-balanced meals throughout the day